Nonoxynol-9 fails to prevents STDs, but microbicide research continues

Affiliations

Comment

David Wilkinson. Lancet. 2002.

. 2002 Sep 28;360(9338):962-3.

doi: 10.1016/S0140-6736(02)11119-6.

¹ Division of Health Sciences, University of South Australia, SA 5000, Adelaide, Australia. david.wilkinson@unisa.edu.au

No abstract available

Comment on

Effectiveness of COL-1492, a nonoxynol-9 vaginal gel, on HIV-1 transmission in female sex workers: a randomised controlled trial.
Van Damme L, Ramjee G, Alary M, Vuylsteke B, Chandeying V, Rees H, Sirivongrangson P, Mukenge-Tshibaka L, Ettiègne-Traoré V, Uaheowitchai C, Karim SS, Mâsse B, Perriëns J, Laga M; COL-1492 Study Group. Van Damme L, et al. Lancet. 2002 Sep 28;360(9338):971-7. doi: 10.1016/s0140-6736(02)11079-8. Lancet. 2002. PMID: 12383665 Clinical Trial.